Jul 23, 2009 by Brian Orelli, PhDThe Impressive Number No One Is Talking AboutFuture growth still looks good for Intuitive Surgical.
Jul 22, 2009 by Brian Orelli, PhDThe Blockbuster Around the CornerByetta sales are improving, but is it enough?
Jul 22, 2009 by Brian Orelli, PhDLevering the GenomeLower revenue can't stop Illumina from turning in a good bottom line.
Jul 21, 2009 by Brian Orelli, PhDFoolish Forecast: Pfizer Meanders Toward MergerViews you can use to get clues on tomorrow's news.
Jul 21, 2009 by Brian Orelli, PhDMerck and Schering: A Less Ugly Bride and GroomSometimes "better than expected" is still bad.
Jul 21, 2009 by Brian Orelli, PhDMonsanto and Dow Create Super Corn Sometimes you need a little help from a friend.
Jul 16, 2009 by Brian Orelli, PhDKeep Your Chin Up, J&JAn FDA advisory committee smacked down its drug candidate.
Jul 16, 2009 by Brian Orelli, PhDThe Doctor Will Video Conference With You NowTelemedicine is on its way.
Jul 15, 2009 by Brian Orelli, PhDLess Inflammation From Abbott's QuarterHumira is headed back in the right direction.
Jul 15, 2009 by Brian Orelli, PhDMonsanto Goes Brown to Make GreenWheat may be brown and dry, but it can still be lucrative.
Jul 14, 2009 by Brian Orelli, PhDDiagnosing a Personalized PartnershipAbbott and Glaxo hook up on diagnostics.
Jul 14, 2009 by Brian Orelli, PhDJ&J Eats a Hard QuarterTough year-over-year comparisons are no match for the health care giant.
Jul 13, 2009 by Brian Orelli, PhDFinally! It's a Win, Isn't It?The FDA is doing more than just pulling drugs off the market.
